What do you think price action will be pre results? im thinking when the trial is complete we should get some serious interest to spring it to 4-6 steadily. However this stock doesn't follow proper trends so you can never tell.
I think this is an easy tell. The stock is completely broken and does not follow biotech rules trading 101. With the current plan, the stock will not move up EVER until after the FDA approves a R-I label which is Q2-3 2019. I do think the company can spike significant interests if they change course and I hope the board seriously considers my suggestions.